WHO says it is SUSPENDING its trial of anti-malaria drug hydoxychloroquine in coronavirus patients
A clinical trial of the anti-malaria drug hydroxychloroquine in coronavirus patients has been suspended amid safety concerns. Hydroxychloroquine has been touted by President Donald Trump and he even revealed he took the medication for two weeks as a prophylactic. But the World Health Organization (WHO) said it was concerned after a study from The Lancet published … Read more
